{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:48:24Z","timestamp":1787993304585,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIH R21 EB020757"],"award-info":[{"award-number":["NIH R21 EB020757"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Commission Horizon 2020","award":["proposal 668039"],"award-info":[{"award-number":["proposal 668039"]}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SCHR 1542\/1-1"],"award-info":[{"award-number":["SCHR 1542\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Anti-angiogenic treatment of glioblastoma (GBM) complicates radiologic monitoring. We evaluated magnetic resonance elastography (MRE) as an imaging tool for monitoring the efficacy of anti-VEGF treatment of GBM.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Longitudinal studies were performed in an orthotopic GBM xenograft mouse model. Animals treated with B20 anti-VEGF antibody were compared to untreated controls regarding survival (<jats:italic>n<\/jats:italic>\u2009=\u200913), classical MRI-contrasts and biomechanics as quantified via MRE (<jats:italic>n<\/jats:italic>\u2009=\u200915). Imaging was performed on a 7\u2009T small animal horizontal bore MRI scanner. MRI and MRE parameters were compared to histopathology.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Anti-VEGF-treated animals survived longer than untreated controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.0011) with progressively increased tumor volume in controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.0001). MRE parameters viscoelasticity |G*| and phase angle Y significantly decreased in controls (<jats:italic>p<\/jats:italic>\u2009=\u20090.02 for |G*| and <jats:italic>p<\/jats:italic>\u2009=\u20090.0071 for Y). This indicates that untreated tumors became softer and more elastic than viscous with progression. Tumor volume in treated animals increased more slowly than in controls, indicating efficacy of the therapy, reaching significance only at the last time point (<jats:italic>p<\/jats:italic>\u2009=\u20090.02). Viscoelasticity and phase angle Y tended to decrease throughout therapy, similar as for control animals. However, in treated animals, the decrease in phase angle Y was significantly attenuated and reached statistical significance at the last time point (<jats:italic>p<\/jats:italic>\u2009=\u20090.04). Histopathologically, control tumors were larger and more heterogeneous than treated tumors. Vasculature was normalized in treated tumors compared with controls, which showed abnormal vasculature and necrosis. In treated tumors, a higher amount of myelin was observed within the tumor area (<jats:italic>p<\/jats:italic>\u2009=\u20090.03), likely due to increased tumor invasion. Stiffness of the contralateral hemisphere was influenced by tumor mass effect and edema.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Anti-angiogenic GBM treatment prolonged animal survival, slowed tumor growth and softening, but did not prevent progression. MRE detected treatment effects on tumor stiffness; the decrease of viscoelasticity and phase angle in GBM was attenuated in treated animals, which might be explained by normalized vasculature and greater myelin preservation within treated tumors. Thus, further investigation of MRE is warranted to understand the potential for MRE in monitoring treatment in GBM patients by complementing existing MRI techniques.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s40644-020-00314-1","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T19:03:26Z","timestamp":1589310206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Magnetic Resonance Elastography reveals effects of anti-angiogenic glioblastoma treatment on tumor stiffness and captures progression in an orthotopic mouse model"],"prefix":"10.1186","volume":"20","author":[{"given":"Katharina","family":"Schregel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal O.","family":"Nowicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miklos","family":"Palotai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Nazari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Zane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Sinkus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-2339","authenticated-orcid":false,"given":"Sean E.","family":"Lawler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Patz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"Suppl 4","key":"314_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/nov189","volume":"17","author":"QT Ostrom","year":"2015","unstructured":"Ostrom QT, Gittleman H, Fulop J, Liu M, Blanda R, Kromer C, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008\u20132012. Neuro-Oncol. 2015;17(Suppl 4):iv1\u201362.","journal-title":"Neuro-Oncol"},{"key":"314_CR2","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987\u201396.","journal-title":"N Engl J Med"},{"key":"314_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.critrevonc.2008.02.005","volume":"67","author":"AA Brandes","year":"2008","unstructured":"Brandes AA, Tosoni A, Franceschi E, Reni M, Gatta G, Vecht C. Glioblastoma in adults. Crit Rev Oncol Hematol. 2008;67:139\u201352.","journal-title":"Crit Rev Oncol Hematol"},{"key":"314_CR4","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, et al. Updated response assessment criteria for high-grade Gliomas: response assessment in Neuro-oncology working group. J Clin Oncol. 2010;28:1963\u201372.","journal-title":"J Clin Oncol"},{"key":"314_CR5","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13311-016-0507-6","volume":"14","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Wen PY, Cloughesy TF. Modified criteria for radiographic response assessment in Glioblastoma clinical trials. Neurotherapeutics. 2017;14:307\u201320.","journal-title":"Neurotherapeutics."},{"key":"314_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/nm0596-601","volume":"2","author":"R Muthupillai","year":"1996","unstructured":"Muthupillai R, Ehman RL. Magnetic resonance elastography. Nat Med. 1996;2:601\u20133.","journal-title":"Nat Med"},{"key":"314_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.mri.2004.11.060","volume":"23","author":"R Sinkus","year":"2005","unstructured":"Sinkus R, Tanter M, Xydeas T, Catheline S, Bercoff J, Fink M. Viscoelastic shear properties of in vivo breast lesions measured by MR elastography. Magn Reson Imaging. 2005;23:159\u201365.","journal-title":"Magn Reson Imaging"},{"key":"314_CR8","doi-asserted-by":"crossref","unstructured":"Murphy MC, Huston J, Ehman RL. MR elastography of the brain and its application in neurological diseases. Neuroimage. 2019;187:176\u201383.","DOI":"10.1016\/j.neuroimage.2017.10.008"},{"key":"314_CR9","doi-asserted-by":"publisher","first-page":"102109","DOI":"10.1016\/j.nicl.2019.102109","volume":"25","author":"A Bunevicius","year":"2020","unstructured":"Bunevicius A, Schregel K, Sinkus R, Golby A, Patz S. REVIEW: MR elastography of brain tumors. Neuroimage Clin. 2020;25:102109.","journal-title":"Neuroimage Clin"},{"key":"314_CR10","doi-asserted-by":"publisher","first-page":"085024","DOI":"10.1088\/1367-2630\/15\/8\/085024","volume":"15","author":"M Simon","year":"2013","unstructured":"Simon M, Guo J, Papazoglou S, Scholand-Engler H, Erdmann C, Melchert U, et al. Non-invasive characterization of intracranial tumors by magnetic resonance elastography. New J Phys. 2013;15:085024.","journal-title":"New J Phys"},{"key":"314_CR11","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00062-014-0311-9","volume":"25","author":"M Reiss-Zimmermann","year":"2015","unstructured":"Reiss-Zimmermann M, Streitberger K-J, Sack I, Braun J, Arlt F, Fritzsch D, et al. High resolution imaging of viscoelastic properties of intracranial Tumours by multi-frequency magnetic resonance Elastography. Clin Neuroradiol. 2015;25:371\u20138.","journal-title":"Clin Neuroradiol"},{"key":"314_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3174\/ajnr.A5415","volume":"39","author":"KM Pepin","year":"2018","unstructured":"Pepin KM, McGee KP, Arani A, Lake DS, Glaser KJ, Manduca A, et al. MR Elastography analysis of Glioma stiffness and IDH1-mutation status. AJNR Am J Neuroradiol. 2018;39:31\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"key":"314_CR13","doi-asserted-by":"publisher","first-page":"e110588","DOI":"10.1371\/journal.pone.0110588","volume":"9","author":"K-J Streitberger","year":"2014","unstructured":"Streitberger K-J, Reiss-Zimmermann M, Freimann FB, Bayerl S, Guo J, Arlt F, et al. High-resolution mechanical imaging of glioblastoma by multifrequency magnetic resonance elastography. PLoS One. 2014;9:e110588.","journal-title":"PLoS One"},{"key":"314_CR14","doi-asserted-by":"crossref","unstructured":"Schregel K, Nazari N, Nowicki MO, Palotai M, Lawler SE, Sinkus R, et al. Characterization of glioblastoma in an orthotopic mouse model with magnetic resonance elastography. NMR Biomed. 2018;31(10):e3840.","DOI":"10.1002\/nbm.3840"},{"key":"314_CR15","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1158\/0008-5472.CAN-14-1997","volume":"75","author":"Y Jamin","year":"2015","unstructured":"Jamin Y, Boult JKR, Li J, Popov S, Garteiser P, Ulloa JL, et al. Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography. Cancer Res. 2015;75:1216\u201324.","journal-title":"Cancer Res"},{"key":"314_CR16","doi-asserted-by":"publisher","first-page":"6121","DOI":"10.1088\/0031-9155\/61\/16\/6121","volume":"61","author":"Y Feng","year":"2016","unstructured":"Feng Y, Clayton EH, Okamoto RJ, Engelbach J, Bayly PV, Garbow JR. A longitudinal magnetic resonance elastography study of murine brain tumors following radiation therapy. Phys Med Biol. 2016;61:6121\u201331.","journal-title":"Phys Med Biol"},{"key":"314_CR17","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307:58\u201362.","journal-title":"Science."},{"key":"314_CR18","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/neuonc\/nop027","volume":"12","author":"JF de Groot","year":"2010","unstructured":"de Groot JF, Fuller G, Kumar AJ, Piao Y, Eterovic K, Ji Y, et al. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro-Oncol. 2010;12:233\u201342.","journal-title":"Neuro-Oncol."},{"key":"314_CR19","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3174\/ajnr.A2397","volume":"32","author":"LC Hygino da Cruz","year":"2011","unstructured":"Hygino da Cruz LC, Rodriguez I, Domingues RC, Gasparetto EL, Sorensen AG. Pseudoprogression and pseudoresponse: imaging challenges in the assessment of posttreatment glioma. AJNR Am J Neuroradiol. 2011;32:1978\u201385.","journal-title":"AJNR Am J Neuroradiol"},{"key":"314_CR20","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/neuonc\/now091","volume":"18","author":"W Wick","year":"2016","unstructured":"Wick W, Chinot OL, Bendszus M, Mason W, Henriksson R, Saran F, et al. Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy\/temozolomide for newly diagnosed glioblastoma. Neuro-Oncol. 2016;18:1434\u201341.","journal-title":"Neuro-Oncol."},{"key":"314_CR21","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8:e1000412.","journal-title":"PLoS Biol"},{"key":"314_CR22","doi-asserted-by":"publisher","first-page":"5374","DOI":"10.1158\/0008-5472.CAN-10-3026","volume":"71","author":"SP Williams","year":"2011","unstructured":"Williams SP, Nowicki MO, Liu F, Press R, Godlewski J, Abdel-Rasoul M, et al. Indirubins decrease glioma invasion by blocking migratory phenotypes in both the tumor and stromal endothelial cell compartments. Cancer Res. 2011;71:5374\u201380.","journal-title":"Cancer Res"},{"key":"314_CR23","doi-asserted-by":"crossref","unstructured":"Garteiser P, Sahebjavaher RS, Ter Beek LC, Salcudean S, Vilgrain V, Van Beers BE, et al. Rapid acquisition of multifrequency, multislice and multidirectional MR elastography data with a fractionally encoded gradient echo sequence. NMR Biomed. 2013;26(10):1326\u201335.","DOI":"10.1002\/nbm.2958"},{"key":"314_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1002\/nbm.1254","volume":"21","author":"MA Green","year":"2008","unstructured":"Green MA, Bilston LE, Sinkus R. In vivo brain viscoelastic properties measured by magnetic resonance elastography. NMR Biomed. 2008;21:755\u201364.","journal-title":"NMR Biomed"},{"key":"314_CR25","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.mri.2012.05.001","volume":"30","author":"A Fedorov","year":"2012","unstructured":"Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin J-C, Pujol S, et al. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30:1323\u201341.","journal-title":"Magn Reson Imaging"},{"key":"314_CR26","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/sj.neo.7900102","volume":"2","author":"JL Rubenstein","year":"2000","unstructured":"Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, et al. Anti-VEGF antibody treatment of Glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia. 2000;2:306\u201314.","journal-title":"Neoplasia."},{"key":"314_CR27","doi-asserted-by":"publisher","first-page":"6650","DOI":"10.1073\/pnas.1200151109","volume":"109","author":"K Schregel","year":"2012","unstructured":"Schregel K, Wuerfel E, Garteiser P, Gemeinhardt I, Prozorovski T, Aktas O, et al. Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography. Proc Natl Acad Sci U S A. 2012;109:6650\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"314_CR28","doi-asserted-by":"crossref","unstructured":"Huang RY, Neagu MR, Reardon DA, Wen PY. Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno\/targeted therapy \u2013 detecting illusive disease, defining response. Front Neurol. 2015 [cited 2017 May 15];6. Available from: http:\/\/journal.frontiersin.org\/article\/10.3389\/fneur.2015.00033\/full.","DOI":"10.3389\/fneur.2015.00033"},{"key":"314_CR29","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11910-009-0035-4","volume":"9","author":"JL Clarke","year":"2009","unstructured":"Clarke JL, Chang S. Pseudoprogression and pseudoresponse: challenges in brain tumor imaging. Curr Neurol Neurosci Rep. 2009;9:241\u20136.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"314_CR30","doi-asserted-by":"publisher","first-page":"3749","DOI":"10.1073\/pnas.1014480108","volume":"108","author":"O Keunen","year":"2011","unstructured":"Keunen O, Johansson M, Oudin A, Sanzey M, Rahim SAA, Fack F, et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc Natl Acad Sci. 2011;108:3749\u201354.","journal-title":"Proc Natl Acad Sci"},{"key":"314_CR31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1056\/NEJMoa1308345","volume":"370","author":"OL Chinot","year":"2014","unstructured":"Chinot OL, Wick W, Mason W, Henriksson R, Saran F, Nishikawa R, et al. Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N Engl J Med. 2014;370:709\u201322.","journal-title":"N Engl J Med"},{"key":"314_CR32","doi-asserted-by":"crossref","unstructured":"Fehlner A, Behrens JR, Streitberger K-J, Papazoglou S, Braun J, Bellmann-Strobl J, et al. Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome. J Magn Reson Imaging JMRI. 2015.","DOI":"10.1002\/jmri.25342"},{"key":"314_CR33","doi-asserted-by":"publisher","first-page":"e29888","DOI":"10.1371\/journal.pone.0029888","volume":"7","author":"KJ Streitberger","year":"2012","unstructured":"Streitberger KJ, Sack I, Krefting D, Pfuller C, Braun J, Paul F, et al. Brain viscoelasticity alteration in chronic-progressive multiple sclerosis. PLoS One. 2012;7:e29888.","journal-title":"PLoS One"},{"key":"314_CR34","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1016\/j.neuroimage.2009.06.018","volume":"49","author":"J Wuerfel","year":"2010","unstructured":"Wuerfel J, Paul F, Beierbach B, Hamhaber U, Klatt D, Papazoglou S, et al. MR-elastography reveals degradation of tissue integrity in multiple sclerosis. NeuroImage. 2010;49:2520\u20135.","journal-title":"NeuroImage."},{"key":"314_CR35","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/mrm.21404","volume":"58","author":"R Sinkus","year":"2007","unstructured":"Sinkus R, Siegmann K, Xydeas T, Tanter M, Claussen C, Fink M. MR elastography of breast lesions: understanding the solid\/liquid duality can improve the specificity of contrast-enhanced MR mammography. Magn Reson Med. 2007;58:1135\u201344.","journal-title":"Magn Reson Med"},{"key":"314_CR36","doi-asserted-by":"publisher","first-page":"5672","DOI":"10.1039\/c3sm50552a","volume":"9","author":"I Sack","year":"2013","unstructured":"Sack I, J\u00f6hrens K, W\u00fcrfel J, Braun J. Structure-sensitive elastography: on the viscoelastic powerlaw behavior of in vivo human tissue in health and disease. Soft Matter. 2013;9:5672\u201380.","journal-title":"Soft Matter"},{"key":"314_CR37","doi-asserted-by":"crossref","unstructured":"Streitberger K-J, Lilaj L, Schrank F, Braun J, Hoffmann K-T, Reiss-Zimmermann M, et al. How tissue fluidity influences brain tumor progression. Proc Natl Acad Sci. 2020;117(1):128\u201334.","DOI":"10.1073\/pnas.1913511116"},{"key":"314_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1002\/jmri.25516","volume":"46","author":"A Fehlner","year":"2017","unstructured":"Fehlner A, Hirsch S, Weygandt M, Christophel T, Barnhill E, Kadobianskyi M, et al. Increasing the spatial resolution and sensitivity of magnetic resonance elastography by correcting for subject motion and susceptibility-induced image distortions. J Magn Reson Imaging JMRI. 2017;46:134\u201341.","journal-title":"J Magn Reson Imaging JMRI."},{"key":"314_CR39","doi-asserted-by":"publisher","first-page":"e3919","DOI":"10.1002\/nbm.3919","volume":"31","author":"C Guenthner","year":"2018","unstructured":"Guenthner C, Kozerke S. Encoding and readout strategies in magnetic resonance elastography. NMR Biomed. 2018;31:e3919.","journal-title":"NMR Biomed"},{"key":"314_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/mrm.25065","volume":"71","author":"CL Johnson","year":"2014","unstructured":"Johnson CL, Holtrop JL, McGarry MDJ, Weaver JB, Paulsen KD, Georgiadis JG, et al. 3D multislab, multishot acquisition for fast, whole-brain MR elastography with high signal-to-noise efficiency. Magn Reson Med. 2014;71:477\u201385.","journal-title":"Magn Reson Med"},{"key":"314_CR41","doi-asserted-by":"publisher","first-page":"e0148652","DOI":"10.1371\/journal.pone.0148652","volume":"11","author":"L Jug\u00e9","year":"2016","unstructured":"Jug\u00e9 L, Pong AC, Bongers A, Sinkus R, Bilston LE, Cheng S. Changes in rat brain tissue microstructure and stiffness during the development of experimental obstructive hydrocephalus. PLoS One. 2016;11:e0148652.","journal-title":"PLoS One"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40644-020-00314-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-020-00314-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:22:00Z","timestamp":1620775320000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-020-00314-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1186\/s40644-020-00314-1","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"23 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All experiments were performed in accordance with the local institutional animal care and use committee (IACUC) and the National Institutes of Health guide for the care and use of Laboratory animals and the results were reported according to the ARRIVE guidelines.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no potential conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}